Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
| Title: | Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial |
|---|---|
| Authors: | Ritchlin, Christopher T *, Kavanaugh, Arthur, Merola, Joseph F, Schett, Georg, Scher, Jose U, Warren, Richard B, Gottlieb, Alice B, Assudani, Deepak, Bedford-Rice, Kathy, Coarse, Jason, Ink, Barbara, McInnes, Iain B |
| Source: | In The Lancet 8-14 February 2020 395(10222):427-440 |
| Database: | ScienceDirect |
| ISSN: | 01406736 |
|---|---|
| DOI: | 10.1016/S0140-6736(19)33161-7 |
| Published in: | The Lancet |
| Language: | English |